Clinical Escherichia coli isolates utilize alpha-hemolysin to inhibit in vitro epithelial cytokine production

Microbes and Infection

Volumn 14, Issue 7-8, 2012, Pages 628-638

  Hilbert, David W ^a   Paulish Miller, Teresa E ^a   Tan, Chee K ^b   Carey, Alison J ^b   Ulett, Glen C ^b   Mordechai, Eli ^a   Adelson, Martin E ^a   Gygax, Scott E ^a   Trama, Jason P ^a  

^a Medical Diagnostic Laboratories LLC   (United States)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Alpha hemolysin; Urinary tract infections; Uropathogenic E. coli

Indexed keywords

ALPHA HEMOLYSIN; GENOMIC DNA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLADDER EPITHELIUM; CYTOKINE PRODUCTION; CYTOKINE SUPPRESSION; CYTOTOXICITY; ENZYME INHIBITION; FEMALE; GENE MUTATION; HEMOLYSIS; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; MICROBIOLOGICAL EXAMINATION; MOLECULAR CLONING; MOUSE; NONHUMAN; OPERON; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ANIMALS; CLONE CELLS; CYTOKINES; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GENETIC VARIATION; HEMOLYSIN PROTEINS; HUMANS; MICE; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

ESCHERICHIA COLI; MURINAE;

EID: 84862242689     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.01.010     Document Type: Article

References (52)

1. Foxman B., Barlow R., D'Arcy H., Gillespie B., Sobel J.D. Urinary tract infection: self-reported incidence and associated costs. Ann. Epidemiol. 2000, 10:509-515.
2. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis. Mon. 2003, 49:71-82.
3. Yamamoto S., Tsukamoto T., Terai A., Kurazono H., Takeda Y., Yoshida O. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J. Urol. 1997, 157:1127-1129.
4. Foxman B., Klemstine K.L., Brown P.D. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann. Epidemiol. 2003, 13:144-150.
5. Mulvey M.A., Lopez-Boado Y.S., Wilson C.L., Roth R., Parks W.C., Heuser J., Hultgren S.J. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 1998, 282:1494-1497.
6. Lane M.C., Mobley H.L. Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int. 2007, 72:19-25.
7. Valle J., Mabbett A.N., Ulett G.C., Toledo-Arana A., Wecker K., Totsika M., Schembri M.A., Ghigo J.M., Beloin C. UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli. J. Bacteriol. 2008, 190:4147-4161.
8. Allsopp L.P., Totsika M., Tree J.J., Ulett G.C., Mabbett A.N., Wells T.J., Kobe B., Beatson S.A., Schembri M.A. UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect. Immun. 2010, 78:1659-1669.
9. Wiles T.J., Kulesus R.R., Mulvey M.A. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 2008, 85:11-19.
10. Schilling J.D., Martin S.M., Hung C.S., Lorenz R.G., Hultgren S.J. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4203-4208.
11. Andersen-Nissen E., Hawn T.R., Smith K.D., Nachman A., Lampano A.E., Uematsu S., Akira S., Aderem A. Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection. J. Immunol. 2007, 178:4717-4720.
12. Song J., Abraham S.N. TLR-mediated immune responses in the urinary tract. Curr. Opin. Microbiol. 2008, 11:66-73.
13. Godaly G., Bergsten G., Hang L., Fischer H., Frendeus B., Lundstedt A.C., Samuelsson M., Samuelsson P., Svanborg C. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J. Leukoc. Biol. 2001, 69:899-906.
14. Ragnarsdottir B., Samuelsson M., Gustafsson M.C., Leijonhufvud I., Karpman D., Svanborg C. Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J. Infect. Dis. 2007, 196:475-484.
15. Lundstedt A.C., McCarthy S., Gustafsson M.C., Godaly G., Jodal U., Karpman D., Leijonhufvud I., Linden C., Martinell J., Ragnarsdottir B., Samuelsson M., Truedsson L., Andersson B., Svanborg C. A genetic basis of susceptibility to acute pyelonephritis. PLoS One 2007, 2:e825.
16. Klumpp D.J., Weiser A.C., Sengupta S., Forrestal S.G., Batler R.A., Schaeffer A.J. Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kappaB. Infect. Immun. 2001, 69:6689-6695.
17. Billips B.K., Forrestal S.G., Rycyk M.T., Johnson J.R., Klumpp D.J., Schaeffer A.J. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect. Immun. 2007, 75:5353-5360.
18. Hilbert D.W., Pascal K.E., Libby E.K., Mordechai E., Adelson M.E., Trama J.P. Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide- and Toll-like receptor 4-independent pathway. Microbes Infect. 2008, 10:114-121.
19. Hunstad D.A., Justice S.S., Hung C.S., Lauer S.R., Hultgren S.J. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect. Immun. 2005, 73:3999-4006.
20. Billips B.K., Schaeffer A.J., Klumpp D.J. Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect. Immun. 2008, 76:3891-3900.
21. Cirl C., Wieser A., Yadav M., Duerr S., Schubert S., Fischer H., Stappert D., Wantia N., Rodriguez N., Wagner H., Svanborg C., Miethke T. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat. Med. 2008, 14:399-406.
22. Bhushan S., Tchatalbachev S., Klug J., Fijak M., Pineau C., Chakraborty T., Meinhardt A. Uropathogenic Escherichia coli block MyD88-dependent and activate MyD88-independent signaling pathways in rat testicular cells. J. Immunol. 2008, 180:5537-5547.
23. Billips B.K., Yaggie R.E., Cashy J.P., Schaeffer A.J., Klumpp D.J. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. J. Infect. Dis. 2009, 200:263-272.
24. Stanley P., Koronakis V., Hughes C. Acylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin function. Microbiol. Mol. Biol. Rev. 1998, 62:309-333.
25. Kerenyi M., Allison H.E., Batai I., Sonnevend A., Emody L., Plaveczky N., Pal T. Occurrence of hlyA and sheA genes in extraintestinal Escherichia coli strains. J. Clin. Microbiol. 2005, 43:2965-2968.
26. Johnson J.R., Owens K., Gajewski A., Kuskowski M.A. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J. Clin. Microbiol. 2005, 43:6064-6072.
27. Cooke E.M., Ewins S.P. Properties of strains of Escherichia coli isolated from a variety of sources. J. Med. Microbiol. 1975, 8:107-111.
28. Opal S.M., Cross A.S., Gemski P., Lyhte L.W. Aerobactin and alpha-hemolysin as virulence determinants in Escherichia coli isolated from human blood, urine, and stool. J. Infect. Dis. 1990, 161:794-796.
29. Smith Y.C., Rasmussen S.B., Grande K.K., Conran R.M., O'Brien A.D. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect. Immun. 2008, 76:2978-2990.
30. Haugen B.J., Pellett S., Redford P., Hamilton H.L., Roesch P.L., Welch R.A. In vivo gene expression analysis identifies genes required for enhanced colonization of the mouse urinary tract by uropathogenic Escherichia coli strain CFT073 dsdA. Infect. Immun. 2007, 75:278-289.
31. Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6640-6645.
32. Ulett G.C., Mabbett A.N., Fung K.C., Webb R.I., Schembri M.A. The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formation. Microbiology 2007, 153:2321-2331.
33. Roos V., Klemm P. Global gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tract. Infect. Immun. 2006, 74:3565-3575.
34. Hilbert D.W., Paulish T.E., Mordechai E., Adelson M.E., Gygax S.E., Trama J.P. Antimicrobial non-susceptibility of cervico-vaginal and rectal Escherichia coli isolates is associated with phylogeny and plasmid carriage. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:1399-1403.
35. Hilbert D.W., Paulish T.E., Mordechai E., Adelson M.E., Trama J.P. O serogroups, phylogeny, and virulence factors of cervicovaginal and rectal Escherichia coli isolates. Eur. J. Clin. Microbiol. Infect. Dis. 2008, 27:1265-1268.
36. May A.K., Gleason T.G., Sawyer R.G., Pruett T.L. Contribution of Escherichia coli alpha-hemolysin to bacterial virulence and to intraperitoneal alterations in peritonitis. Infect. Immun. 2000, 68:176-183.
37. Johnson D.E., Lockatell C.V., Russell R.G., Hebel J.R., Island M.D., Stapleton A., Stamm W.E., Warren J.W. Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice. Infect. Immun. 1998, 66:3059-3065.
38. Swenson D.L., Bukanov N.O., Berg D.E., Welch R.A. Two pathogenicity islands in uropathogenic Escherichia coli J96: cosmid cloning and sample sequencing. Infect. Immun. 1996, 64:3736-3743.
39. Samuelsson P., Hang L., Wullt B., Irjala H., Svanborg C. Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect. Immun. 2004, 72:3179-3186.
40. Saverino D., Schito A.M., Mannini A., Penco S., Bassi A.M., Piatti G. Quinolone/fluoroquinolone susceptibility in Escherichia coli correlates with human polymicrobial bacteriuria and with in vitro interleukine-8 suppression. FEMS Immunol. Med. Microbiol. 2011, 61:84-93.
41. Ulett G.C., Webb R.I., Ulett K.B., Cui X., Benjamin W.H., Crowley M., Schembri M.A. Group B Streptococcus (GBS) urinary tract infection involves binding of GBS to bladder uroepithelium and potent but GBS-specific induction of interleukin 1alpha. J. Infect. Dis. 2010, 201:866-870.
42. Nagy G., Altenhoefer A., Knapp O., Maier E., Dobrindt U., Blum-Oehler G., Benz R., Emody L., Hacker J. Both alpha-haemolysin determinants contribute to full virulence of uropathogenic Escherichia coli strain 536. Microbes Infect. 2006, 8:2006-2012.
43. Mobley H.L., Green D.M., Trifillis A.L., Johnson D.E., Chippendale G.R., Lockatell C.V., Jones B.D., Warren J.W. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 1990, 58:1281-1289.
44. Bauer M.E., Welch R.A. Pleiotropic effects of a mutation in rfaC on Escherichia coli hemolysin. Infect. Immun. 1997, 65:2218-2224.
45. Wandersman C., Letoffe S. Involvement of lipopolysaccharide in the secretion of Escherichia coli alpha-haemolysin and Erwinia chrysanthemi proteases. Mol. Microbiol. 1993, 7:141-150.
46. Real J.M., Munro P., Buisson-Touati C., Lemichez E., Boquet P., Landraud L. Specificity of immunomodulator secretion in urinary samples in response to infection by alpha-hemolysin and CNF1 bearing uropathogenic Escherichia coli. Cytokine 2007, 37:22-25.
47. Jantausch B.A., O'Donnell R., Wiedermann B.L. Urinary interleukin-6 and interleukin-8 in children with urinary tract infection. Pediatr. Nephrol. 2000, 15:236-240.
48. Benson M., Jodal U., Agace W., Hellstrom M., Marild S., Rosberg S., Sjostrom M., Wettergren B., Jonsson S., Svanborg C. Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria. J. Infect. Dis. 1996, 174:1080-1084.
49. Island M.D., Cui X., Foxman B., Marrs C.F., Stamm W.E., Stapleton A.E., Warren J.W. Cytotoxicity of hemolytic, cytotoxic necrotizing factor 1-positive and -negative Escherichia coli to human T24 bladder cells. Infect. Immun. 1998, 66:3384-3389.
50. Konig B., Konig W. Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin). Immunology 1993, 78:526-533.
51. Bhushan S., Hossain H., Lu Y., Geisler A., Tchatalbachev S., Mikulski Z., Schuler G., Klug J., Pilatz A., Wagenlehner F., Chakraborty T., Meinhardt A. Uropathogenic E. coli induce different immune response in testicular and peritoneal macrophages: implications for testicular immune privilege. PLoS One 2011, 6:e28452.
52. Wiles T.J., Dhakal B.K., Eto D.S., Mulvey M.A. Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins. Mol. Biol. Cell 2008, 19:1427-1438.